Metformin in Breast Cancer: Time for Action

被引:157
作者
Goodwin, Pamela J. [1 ,2 ]
Ligibel, Jennifer A. [3 ]
Stambolic, Vuk [4 ]
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[4] Univ Hlth Network, Ontario Canc Inst, Div Signaling Biol, Toronto, ON, Canada
关键词
ACTIVATED PROTEIN-KINASE; INSULIN; TARGET; PATHWAY; RISK;
D O I
10.1200/JCO.2009.22.1630
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3271 / 3273
页数:3
相关论文
共 19 条
[1]  
ALIMOVA IN, 2009, CELL CYCLE, V26, P8
[2]   The PIK3CA gene is mutated with high frequency in human breast cancers [J].
Bachman, KE ;
Argani, P ;
Samuels, Y ;
Silliman, N ;
Ptak, J ;
Szabo, S ;
Konishi, H ;
Karakas, B ;
Blair, BG ;
Lin, C ;
Peters, BA ;
Velculescu, VE ;
Park, BH .
CANCER BIOLOGY & THERAPY, 2004, 3 (08) :772-775
[3]   Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin [J].
Bowker, SL ;
Majumdar, SR ;
Veugelers, P ;
Johnson, JA .
DIABETES CARE, 2006, 29 (02) :254-258
[4]  
Cusi K, 1998, DIABETES REV, V6, P89
[5]   Metformin and reduced risk of cancer in diabetic patients [J].
Evans, JMM ;
Donnelly, LA ;
Emslie-Smith, AM ;
Alessi, DR ;
Morris, AD .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7503) :1304-1305
[6]   Insulin in the adjuvant breast cancer setting: A novel therapeutic target for lifestyle and pharmacologic interventions? [J].
Goodwin, Pamela J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) :833-834
[7]   Targeting AMPK: A new therapeutic opportunity in breast cancer [J].
Hadad, Sirwan M. ;
Fleming, Stewart ;
Thompson, Alastair M. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 67 (01) :1-7
[8]   Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model [J].
Hadad, Sirwan M. ;
Appleyard, Virginia ;
Thompson, Alastair M. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (02) :391-391
[9]   TSC2 mediates cellular energy response to control cell growth and survival [J].
Inoki, K ;
Zhu, TQ ;
Guan, KL .
CELL, 2003, 115 (05) :577-590
[10]   Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer [J].
Jiralerspong, Sao ;
Palla, Shana L. ;
Giordano, Sharon H. ;
Meric-Bernstam, Funda ;
Liedtke, Cornelia ;
Barnett, Chad M. ;
Hsu, Limin ;
Hung, Mien-Chie ;
Hortobagyi, Gabriel N. ;
Gonzalez-Angulo, Ana M. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) :3297-3302